Although major insights have come from research on mouse models, there are overwhelming data on the increased stability of HIF-1α or HIF-2α expression in human cancer, promoting progression and worsening prognosis in human solid cancers such as breast, prostate, and colorectal cancer (55–57). Here, HIF1A is linked to cancer.